We are live on ! Find out more
BCIM

British Columbia Investment Management Portfolio holdings

AUM $17B
1-Year Est. Return 31.69%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+31.69%
3 Year Est. Return
+89.35%
5 Year Est. Return
+112.26%
10 Year Est. Return
+424.53%
AUM
$13.4B
AUM Growth
+$3.12B
Cap. Flow
+$2.23B
Cap. Flow %
16.57%
Top 10 Hldgs %
21.06%
Holding
848
New
62
Increased
545
Reduced
201
Closed
25

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$222M
2
BA icon
Boeing
BA
+$204M
3
C icon
Citigroup
C
+$195M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$164M
5
AMZN icon
Amazon
AMZN
+$150M

Top Sells

Rank Stock Value
1
ENB icon
Enbridge
ENB
+$50.3M
2
PG icon
Procter & Gamble
PG
+$25.2M
3
CELG
Celgene Corp
CELG
+$20.8M
4
MRK icon
Merck
MRK
+$18M
5
XYL icon
Xylem
XYL
+$17.5M

Sector Composition

Rank Sector Weight
1 Financials 20.98%
2 Technology 15.38%
3 Healthcare 10.98%
4 Industrials 10.85%
5 Consumer Discretionary 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTX icon
76
RTX Corp
RTX
$300B
$43.9M 0.33%
466,252
+249,422
+115% +$22.6M
XYL icon
77
Xylem
XYL
$28.5B
$43.9M 0.33%
557,422
-224,422
-29% -$17.5M
SCI icon
78
Service Corp International
SCI
$11.5B
$42M 0.31%
913,250
+209,250
+30% +$9.44M
PINC
79
DELISTED
Premier
PINC
$40.9M 0.3%
1,078,901
+99,151
+10% +$3.49M
GS icon
80
Goldman Sachs
GS
$302B
$40.6M 0.3%
176,362
+127,665
+262% +$27.7M
WPM icon
81
Wheaton Precious Metals
WPM
$61.3B
$40.4M 0.3%
1,358,779
+98,247
+8% +$2.69M
MET icon
82
MetLife
MET
$61.4B
$40.2M 0.3%
787,741
+673,352
+589% +$32.5M
WMT icon
83
Walmart Inc
WMT
$923B
$40M 0.3%
1,010,460
+241,884
+31% +$9.61M
CM icon
84
Canadian Imperial Bank of Commerce
CM
$110B
$39.7M 0.3%
954,684
+263,114
+38% +$11.1M
B
85
Barrick Mining
B
$67.9B
$39.5M 0.29%
2,127,880
-484,983
-19% -$8.32M
ADBE icon
86
Adobe
ADBE
$103B
$37.8M 0.28%
114,551
-16,253
-12% -$4.78M
MMM icon
87
3M
MMM
$94.8B
$37.2M 0.28%
252,057
+76,475
+44% +$10.7M
ABT icon
88
Abbott
ABT
$192B
$36.2M 0.27%
417,060
+13,299
+3% +$1.11M
MDT icon
89
Medtronic
MDT
$116B
$35.9M 0.27%
316,600
+4,888
+2% +$536K
BMY icon
90
Bristol-Myers Squibb
BMY
$130B
$35.5M 0.26%
553,243
-26,540
-5% -$1.52M
SBUX icon
91
Starbucks
SBUX
$124B
$34.3M 0.26%
390,365
-16,060
-4% -$1.37M
AMGN icon
92
Amgen
AMGN
$225B
$34.1M 0.25%
141,513
-15,981
-10% -$3.52M
NFLX icon
93
Netflix
NFLX
$309B
$33.4M 0.25%
1,033,170
-126,730
-11% -$3.76M
PBA icon
94
Pembina Pipeline
PBA
$28.4B
$32.5M 0.24%
877,020
-344,889
-28% -$12.3M
NVDA icon
95
NVIDIA
NVDA
$5.43T
$32.1M 0.24%
5,460,880
-2,460,080
-31% -$12.8M
CRM icon
96
Salesforce
CRM
$158B
$32M 0.24%
196,601
-68,922
-26% -$10.8M
PPG icon
97
PPG Industries
PPG
$25.5B
$31.5M 0.23%
236,310
+141,088
+148% +$17.9M
PM icon
98
Philip Morris
PM
$290B
$31.2M 0.23%
367,138
+96,866
+36% +$7.98M
ABBV icon
99
AbbVie
ABBV
$440B
$30.9M 0.23%
348,884
-150,889
-30% -$12.5M
TMO icon
100
Thermo Fisher Scientific
TMO
$223B
$30.7M 0.23%
94,501
-2,106
-2% -$639K

Similar funds

British Columbia Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, British Columbia Investment Management held 848 positions worth $13.4B, up 30% from $10.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

British Columbia Investment Management deployed $2.23B of net new capital in Q4 2019, opening 62 new positions and adding to 545 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 583,000 shares worth $96.6M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Enbridge, an estimated $50.3M trimmed.

  • British Columbia Investment Management's largest Q4 2019 buy was iShares Russell 2000 ETF: 583,000 shares worth $96.6M.
  • British Columbia Investment Management added most to Allergan plc in Q4 2019, an estimated $222M increase.
  • British Columbia Investment Management's biggest Q4 2019 reduction was Enbridge, cutting an estimated $50.3M.
  • British Columbia Investment Management fully exited Celgene Corp in Q4 2019, selling an estimated $20.8M.
  • British Columbia Investment Management's ten largest holdings make up 21% of its $13.4B portfolio in Q4 2019.
  • British Columbia Investment Management opened 62 new positions and closed 25 in Q4 2019.
  • British Columbia Investment Management's portfolio value rose 30% quarter-over-quarter to $13.4B.

Based on British Columbia Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.